Warren Averett Asset Management, LLC Humacyte, Inc. Transaction History
Warren Averett Asset Management, LLC
- $9.72 Billion
- Q3 2025
A detailed history of Warren Averett Asset Management, LLC transactions in Humacyte, Inc. stock. As of the latest transaction made, Warren Averett Asset Management, LLC holds 267,041 shares of HUMA stock, worth $315,108. This represents 0.0% of its overall portfolio holdings.
Number of Shares
267,041
Previous 270,854
1.41%
Holding current value
$315,108
Previous $566,000
18.02%
% of portfolio
0.0%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding HUMA
# of Institutions
157Shares Held
43.2MCall Options Held
383KPut Options Held
648K-
Vanguard Group Inc Valley Forge, PA7.52MShares$8.87 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.14MShares$8.43 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.1MShares$3.65 Million0.0% of portfolio
-
State Street Corp Boston, MA2.41MShares$2.84 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.1MShares$2.47 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $122M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...